What is the difference in expression of CD15 in normal vs. leukemic promyelocytes?
What is the immunophenotype of APL?
What are the differences of the immunophenotype in the microgranular variant of APL?
The expression of CD2 in the microgranular variant of APL has been associated with what?
Are there any differences in the immunophenotype of therapy-related APL or APL with variant translocations?
What is CD56 expression by APL associated with?
What other types of blast morphology (non APL) have been described in association with a negative CD34 and HLA-DR?
What are some immunophenotypic similarities of APL to monocytic leukemias ?
How can APL be immunophenotypically differentiated from a monocytic leukemia?
After therapy, immunophenotypes of APL may change. What are some changes that may be seen occasionally?
What can be seen in APL at relapse?